Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant

Vaccine

Volumn 22, Issue 23-24, 2004, Pages 3092-3097

  Barouch, Dan H ^a   Truitt, Diana M ^a   Letvin, Norman L ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cytokine; DNA; HIV 1

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN; INTERLEUKIN 2;

ARTICLE; CYTOKINE PRODUCTION; IMMUNE RESPONSE; IMMUNOGENICITY; KINETICS; MONKEY; PLASMID; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; INJECTIONS, INTRAMUSCULAR; INTERLEUKIN-2; KINETICS; MACACA MULATTA; MICE; MICE, INBRED BALB C; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; VACCINES, DNA;

EID: 3843121038     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.065     Document Type: Article

References (13)

1. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Ann. Rev. Immunol. 15:1997;617-648
2. Wang R., Doolan D.L., Le T.P., Hedstrom R.C., Coonan K.M., Charoenvitet Y., et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480
3. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Gluckman S.J., Bagarazzi M.L., et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178:1998;92-100
4. Calarota S., Bratt G., Nordlund S., Hinkula J., Leandersson A.C., Sandstrom E., et al. Cellular cytotoxic response induced by DNA vaccination in HIV-1 - infected patients. Lancet. 351:1998;1320-1325
5. Xiang Z., Ertl H.C.J. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135
6. Barouch D.H., Santra S., Steenbeke T.D., Zheng X.X., Perry H.C., Davies M.E., et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J. Immunol. 161:1998;1875-1882
7. Barouch D.H., Craiu A., Kuroda M.J., Schmitz J.E., Zheng X.X., Santra S., et al. Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys. Proc. Natl. Acad. Sci. U.S.A. 97:2000;4192-4197
8. Barouch D.H., Santra S., Schmitz J.E., Kuroda M.J., Fu T.M., Wagner W., et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 290:2000;486-492
9. 4+ T cell responses elicited by a bicistronic HIV-1 DNA vaccine expressing gp120 and GM-CSF. J. Immunol. 168:2002;562-568
10. Sedegah M., Weiss W., Sacci J.B., Charoenvit Y., Hedstrom R., Gowda K., et al. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expresing recombinant poxvirus. J. Immunol. 164:2000;5905-5912
11. Weiss W.R., Ishii K.J., Hedstrom R.C., Sedegah M., Ichino M., Barnhartet K., et al. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine. J. Immunol. 161:1998;2325-2332
12. Premenko-Lanier M., Rota P.A., Rhodes G., Verhoeven D., Barouch D.H., Lerche N.W., et al. DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate. Virology. 302:2003;67-75
13. Parker S.E., Monteith D., Horton H., Hof R., Hernandez P., Vilalta A., et al. Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther. 8:2001;1011-1023